IYR iShares U.S. Real Estate ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| WELL | 10.09% |
| PLD | 9.16% |
| EQIX | 4.71% |
| DLR | 4.62% |
| SPG | 4.53% |
| O | 4.47% |
| AMT | 4.42% |
| PSA | 3.42% |
| VTR | 3.17% |
| CBRE | 3.12% |
ETF Analysis
Fund Overview
iShares U.S. Real Estate ETF (IYR) currently reports 61 stock positions (subject to change), placing it in the mid-range in diversification range by holdings breadth. The top line-up is WELL (10.09%), PLD (9.16%), EQIX (4.71%), with WELL as the largest single weight at 10.09%. Together, the top three holdings account for 23.96%, which implies a more democratized weight structure where the broader holding set matters as much as the leadership group. This structure gives the portfolio a dual character: meaningful exposure to its highest-conviction names, alongside enough breadth to dampen idiosyncratic noise.
Profitability & Capital Efficiency
Examining the portfolio through a capital allocation lens, ROIC is 4.71%, WACC is 7.83%, and the economic spread is -3.12%. On balance, the economic spread is negative, indicating that at current return levels, reinvestment is value-destructive in aggregate. Supporting metrics show ROE at 13.24% and ROA at 3.00%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that likely needs operating improvement before returns quality can be considered durable.
Valuation
Turning to how the market is pricing the underlying earnings, trailing P/E of 24.25, forward P/E of 30.67, PEG of 10.74. Trailing and forward valuations are closely aligned, pointing to a market that is pricing continuity rather than improvement in the earnings outlook. On a growth-adjusted basis, the portfolio is expensive — the current multiple requires strong earnings delivery to be justified on conventional valuation metrics. The aggregate current ratio of 1.72 reflects a holding set with workable near-term liquidity positions. The combined picture across P/E, forward P/E, PEG, and current ratio suggests a portfolio that is priced for continued execution — where disappointment would be costly and outperformance would likely require positive earnings surprises.
Margins & Cash Generation
From gross to free cash flow, gross margin sits at 65.33%, operating margin at 32.40%, and free cash flow margin at 14.87%. At this level, gross margins reflect the kind of pricing power and cost insulation that characterizes category-leading businesses. The portfolio's operating margins are well above average, pointing to businesses that manage the full cost stack with discipline. The portfolio's FCF margin is modest — adequate for near-term needs but not indicative of exceptional capital efficiency. The margin profile warrants careful consideration — businesses with compressed margins have less room to absorb cost pressure or revenue softness.
Growth & Forward Outlook
Combining revenue momentum with analyst targets, the estimated 12-month price change of 13.71%, where consensus expectations favor gradual appreciation over the next year, while TTM revenue growth of 14.83% reflecting moderate but reliable revenue progress across the basket. Separating operating reality from market-implied expectations is useful here — they can diverge meaningfully when sentiment shifts. The forward return case hinges on whether the operating reality stays close enough to analyst assumptions for those targets to remain credible. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
HoldThe composite read is moderately constructive but uneven — in the absence of a clear catalyst, a neutral stance is well-supported by the data.
This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.